One Blockbuster Drug Explains A Lot About Our Out-Of-Control Healthcare Costs

Medicare, the federal health insurance program for Americans 65 and older, could save $18 billion over the next 10 years if doctors switch to a less expensive drug to treat blindness. The switch could also save patients $5 billion in insurance copayments, according to a new study in Health Affairs. Ranibizumab, more commonly known by its brand name Lucentis, is delivered as an injection to the eye and runs about $2,023 per dose. Many patients require up to 12 injections per year. That's why some...